Pediatric complicated pneumonia and pneumococcal serotype replacement: Trends in hospitalized children pre and post introduction of routine vaccination with Pneumococcal Conjugate Vaccine (PCV7)

European Journal of Pediatrics

Volumn 169, Issue 9, 2010, Pages 1123-1128

  Chibuk, Thea K ^a   Robinson, Joan L ^a   Hartfield, Dawn S ^a  

^a STOLLERY CHILDREN S HOSPITAL   (Canada)

Author keywords

Complicated pneumonia; Empyema; Pneumococcal; Pneumococcal vaccine

Indexed keywords

HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ARTICLE; CANADA; CHILD; CHILD HOSPITALIZATION; FEMALE; HUMAN; IMMUNOLOGY; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SEROTYPING; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ALBERTA; CHILD; CHILD, HOSPITALIZED; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 79952113657     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-010-1195-6     Document Type: Article

References (31)

1. Advisory Committee on Immunization Practices (2000) Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 49 (RR-9):1-35
2. Alberta Health and Wellness Website on Immunizations. http://www.health.gov.ab.ca/public/immunization.html. Accessed July 2008
3. Ampofo K, Bender J, Sheng X et al (2008) Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 122(2):229-237
4. Buckingham SC, King MD, Miller ML (2003) Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr Infect Dis J 22(6):499-504 (Pubitemid 36782188)
5. Byington CL, Korgenski K, Daly J et al (2006) Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 25(3):250-254 (Pubitemid 43379067)
6. Byington CL, Samore MH, Stoddard GJ et al (2005) Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 41(1):21-29 (Pubitemid 40863739)
7. Byington CL, Spencer LY, Johnson TA et al (2002) An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 34(4):434-440 (Pubitemid 34112262)
8. Centers for Disease Control and Prevention (CDC) (2009) Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine - United States, 1997-2006. MMWR Morb Mortal Wkly Rep 58(1):1-4
9. Centers for Disease Control and Prevention (CDC) (2008) Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction-eight states, 1998-2005. MMWR Morb Mortal Wkly Rep 57(6):144-148
10. Dagan R (2009) Serotype replacement in perspective. Vaccine 27 (Suppl 3):C22-C24
11. Fletcher M, Leeming J, Cartwright K et al (2006) Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 25(6):559-560 (Pubitemid 43863370)
12. Goldbart AD, Leibovitz E, Porat N et al (2009) Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine. Scand J Infect Dis 41(3):182-187
13. Harboe ZB, Benfield TL, Valentiner-Branth P et al (2010) Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis 50(3):329-337
14. Hendrickson DJ, Blumberg DA, Joad JP et al (2008) Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 27 (11):1030-1032
15. Hicks LA, Harrison LH, Flannery B et al (2007) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 196:1346-1354 (Pubitemid 351412007)
16. Jansen AG, Sanders EA, van der Ende A et al (2008) Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncitial virus activity. Epidemiol Infect 136(11):1448-1454
17. Karlowsky JA, Lagacé-Wiens PR, Low DE et al (2009) Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005. Int J Antimicrob Agents 34(4):375-379
18. Kellner JD, Vanderkooi OG, MacDonald J et al (2009) Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis 49(2):205-212
19. Langley JM, Kellner J, Solomon N et al (2008) Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect Dis 8:129
20. Li ST, Tancredi DJ (2010) Empyema hospitalizations increased in US despite pneumococcal conjugate vaccine. Pediatrics 125 (1):26-33
21. Rees JH, Spencer DA, Parikh D et al (1997) Increase in incidence of childhood empyema in West Midlands, UK. The Lancet 349:402-404
22. Rennels MB, Edwards KM, Keyserling HL et al (1998) Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics 101:604-611
23. Schultz KD, Fan LL, Pinsky J et al (2004) The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 113(6):1735-1740 (Pubitemid 38697984)
24. Tan TQ, Mason EO Jr, Wald ER et al (2002) Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 110(1 Pt 1):1-6 (Pubitemid 34742634)
25. Tarrago D, Fenoll A, Sanchez-Tatay D et al (2008) Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect 14 (9):828 -834
26. Tsai CJ, Griffin MR, Nuorti JP et al (2008) Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 46(11):1664-1672
27. Tyrell GJ, Lovgren M, Chui N et al (2009) Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006. Vaccine 27(27):3553-3560
28. Van Ackere T, Proesmans M, Vermeulen F et al (2009) Complicated parapneumonic effusion in Belgian children: increased occurrence before routine pneumococcal vaccine implementation. Eur J Pediatr 168:51-58
29. Van Gils EJ, Veenhoven RH, Hak E et al (2009) Effect of reduced-dose schedules with a 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized control trial. JAMA 302(2):159-167
30. Whitney CG, Farley MM, Hadler J et al (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348(18):1737-1746 (Pubitemid 36514704)
31. Winther TN, Kristensen TD, Kaltoft MS et al (2008) Invasive pneumococcal disease in Danish children, 1996-2007, prior to the introduction of heptavalent pneumococcal conjugate vaccine. Acta Paediatr 98(2):328-331